Interleukin-10 Producing T Lymphocytes Attenuate Dermal Scarring

Area of Science:

• Immunology
• Dermatology
• Wound Healing Research

Background:

• CD4+ T cells are crucial for wound healing and fibrosis prevention.
• The specific role of CD4+ subsets, particularly IL-10 producers, in fibrosis remains unclear.
• IL-10 is an anti-inflammatory cytokine known to promote regenerative healing.

Purpose of the Study:

• To investigate the impact of IL-10 producing T lymphocytes on mediating dermal scarring.
• To determine if IL-10 producing CD4+ T lymphocyte subsets can attenuate dermal wound fibrosis.

Main Methods:

• Adoptive transfer of IL-10-/- and wild-type murine CD4+ lymphocytes into SCID mice with full-thickness wounds.
• Analysis of inflammation and collagen content at days 7 and 28 post-wounding.
• Sorting and transfer of T naive and type 1 regulatory (Tr1) T cell subsets into wounds, with subsequent in vitro co-culture of fibroblasts with these cells.

Main Results:

• Loss of anti-inflammatory and antifibrotic effects in SCID mice receiving CD4+ cells from IL-10-/- mice.
• Accelerated wound closure (day 7) and reduced fibrosis (day 28) in SCID mice receiving Tr1 cells.
• Tr1 cells promoted hyaluronan production by fibroblasts, an extracellular matrix component linked to IL-10-induced regenerative healing.

Conclusions:

• IL-10 producing T lymphocytes, specifically Tr1 cells, regulate inflammatory cytokine expression.
• Tr1 cells promote hyaluronan-rich extracellular matrix deposition, thereby attenuating fibrosis.
• Enhancing IL-10 producing lymphocytes in wounds represents a potential therapeutic strategy for promoting regenerative healing.